Quantitative Assessment of the Effect of LRRK2 Exonic Variants on the Risk of Parkinson’s Disease: A Meta-Analysis

Xi Wu,Kefu Tang,Yang Li,Yüting Xiong,Lu Shen,Zengxin Wei,Kecheng Zhou,Jiamin Niu,Xuelei Han,Lun Yang,Feng Gao,Lin He,Shengying Qin

DOI: https://doi.org/10.1016/j.parkreldis.2012.04.013

2012-01-01

Abstract:Leucine-rich repeat kinase 2 (LRRK2, PARK8) gene has attracted considerable attention since the variants in this gene are recognized as the most common cause of Parkinson’s disease (PD) so far. A number of association studies concerning variants of LRRK2 gene and PD susceptibility have been conducted in various populations. However, some results were inconclusive. To derive a more precise estimation of the relationship between LRRK2 and genetic risk of PD, we performed a comprehensive meta-analysis which included 27,363 cases and 29,741 controls from 61 published case–control studies. Totally, the effect of five LRRK2 variants all within the coding regions, i.e. G2019S, G2385R, R1628P, P755L and A419V, were evaluated in the meta-analysis using fixed effect model or random effects model if heterogeneity existed. There were genetic associations between four variants (G2019S, G2385R, R1628P and A419V) and increased PD risk, while there was no evidence of statistically significant association between P755L and PD. Publication bias and heterogeneity were absent in most analyses. Within its limitations, this meta-analysis demonstrated that the G2019S, G2385R, R1628P and A419V variations are risk factors associated with increased PD susceptibility. However, these associations vary in different ethnicities.